(Q52281088)
Statements
Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost-utility analysis based on a modified Q-TWIST method. (English)
1 reference
Trippoli S
1 reference
Becagli P
1 reference
Messori A
1 reference
1 January 1997
1 reference
53
1 reference
3-4
1 reference
281-282
1 reference